Science News Today
  • Biology
  • Physics
  • Chemistry
  • Astronomy
  • Health and Medicine
  • Psychology
  • Earth Sciences
  • Archaeology
  • Technology
Science News Today
  • Biology
  • Physics
  • Chemistry
  • Astronomy
  • Health and Medicine
  • Psychology
  • Earth Sciences
  • Archaeology
  • Technology
No Result
View All Result
Science News Today
No Result
View All Result
Home Health and Medicine

New Study Uncovers How Cancer Drugs Could Heal the Brain After Stroke

by Muhammad Tuhin
June 13, 2025
Middle cerebral artery occlusion and gross neurological status upon HDACi treatment. Credit: Glia (2025). DOI: 10.1002/glia.70035

Middle cerebral artery occlusion and gross neurological status upon HDACi treatment. Credit: Glia (2025). DOI: 10.1002/glia.70035

0
SHARES

Stroke, a sudden assault on the brain’s lifeblood, continues to rank among the leading causes of death and disability worldwide. With millions of lives forever changed each year—through paralysis, speech loss, and cognitive decline—the aftermath of a stroke often feels like a battle only half-won. Current treatments focus narrowly on restoring blood flow, and time is the cruelest factor: if you miss the narrow window, options rapidly fade. But what if healing could begin after that window closes?

You might also like

America’s Babies Are Missing Gut Guardians That Protect Them for Life

The Hidden Heart Risks of Sleeping in Brightness

When Vision Fades, the Eye Fights Back with Hidden Networks

In a groundbreaking new study, scientists at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have found that a class of drugs currently used in cancer therapy could be repurposed to limit brain damage and boost recovery following ischemic stroke. The key lies not in blood vessels, but in the brain’s own immune cells: microglia.

Rewiring the Brain’s First Responders

Led by Professor S. Thameem Dheen, Dr. Kevin Jayaraj, and Dr. Jai S. Polepalli, the NUS Medicine research team has revealed that histone deacetylase inhibitors (HDACi), drugs already being tested for cancer and Alzheimer’s, can switch microglia from harmful instigators of inflammation into protectors of neurons.

Published in the prestigious journal Glia, the study represents a major step forward in addressing what scientists call the “second wave” of brain injury—a storm of inflammation that occurs hours to days after stroke, causing additional damage even after the initial attack has passed.

“HDACi are already being explored in cancer and neurodegeneration therapy,” said Prof Dheen. “What we now show is that they can be repurposed to dampen inflammation in the brain and promote recovery in stroke, through a microglia-centric mechanism.”

Stroke, Inflammation, and the Search for Better Treatments

An ischemic stroke—where a blood vessel supplying the brain becomes blocked—triggers a chain reaction of devastation. Neurons die from lack of oxygen. Tissues swell. Immune cells rush in, releasing molecules meant to clean up damage but often worsening it instead.

Among the immune responders are microglia, specialized brain cells that act like paramedics and janitors. In healthy brains, they clear debris and help with neural repair. But after a stroke, microglia can turn against the tissue they’re meant to protect—amplifying inflammation, killing off vulnerable neurons, and slowing recovery.

Until now, few treatments have aimed to control this second wave of injury.

But the NUS researchers used cutting-edge tools like spatial transcriptomics—a method that maps gene activity across specific brain regions—to peer into the behavior of microglia following stroke and HDACi treatment. What they found was astonishing: in laboratory models, HDACi therapy not only slashed brain damage by 60%, but also reprogrammed microglia into repair mode.

Mapping the Brain’s Molecular Rebirth

To simulate stroke, researchers blocked blood flow in the middle cerebral artery of animal models. Then they introduced HDACi therapy and monitored what happened at both molecular and behavioral levels. The results were striking: not only did HDACi reduce tissue damage, but treated animals also showed improved performance in behavioral tests that measure memory, coordination, and emotional response.

At the cellular level, spatial transcriptomics revealed that microglia in HDACi-treated brains were no longer flooding the environment with inflammatory signals. Instead, they were expressing genes linked to neuroprotection, phagocytosis (clearing cellular debris), and cell survival.

Even more intriguing, these changes weren’t uniform across the brain. The effects were region-specific, with critical zones like the hippocampus—a structure involved in memory—showing particularly robust shifts in microglial behavior.

“Our study demonstrates for the first time that HDACi can restore neuroprotective gene activity in microglia in a region-specific manner across the brain, including critical areas such as the hippocampus,” explained Dr. Jayaraj. “This gives us new therapeutic targets for conditions where neuroinflammation plays a major role.”

From Cancer to Stroke Recovery

HDACi drugs work by modifying gene expression. They alter how tightly DNA is wound around histone proteins, essentially turning genes on or off without changing the genetic code. This ability to reprogram cells has made them useful in treating certain cancers and neurodegenerative diseases.

Now, thanks to this study, they’re being looked at through a new lens—as tools to fine-tune immune responses in the injured brain.

Professor Thiruma V. Arumugam, co-author of the study from La Trobe University in Australia, underscored the implications: “HDACi drugs precisely reprogram microglia in stroke-affected brain regions, transforming them from inflammatory agents to healing promoters. By targeting these immune cells, our study has the potential to address both acute damage and long-term recovery post-stroke.”

This dual-action approach—minimizing initial damage and boosting later repair—is a game-changer. Most current stroke therapies are limited by time; clot-busting drugs must be administered within hours, and beyond that window, options dwindle. But HDACi may offer a longer therapeutic horizon, acting days after stroke onset.

A New Chapter in Neurorehabilitation

The findings could transform not just how we treat stroke, but how we think about recovery. Instead of passively waiting for the brain to heal—or accepting irreversible damage—doctors might someday use medications to actively retrain the brain’s immune system.

The team’s next goal is to develop therapies that can operate beyond the acute phase of stroke. This means crafting strategies that work days or even weeks later, targeting glial cells like microglia to rebuild neural circuits, preserve brain function, and enhance rehabilitation outcomes.

In a world where stroke survivors often face a lifetime of disability, even modest improvements in recovery could transform millions of lives.

Hope Beyond Stroke

The implications ripple far beyond stroke. Microglial dysfunction has been implicated in diseases ranging from Alzheimer’s to multiple sclerosis and traumatic brain injury. If HDACi drugs can safely and effectively recalibrate microglia, they could become a cornerstone of future neurotherapies.

Still, challenges remain. Translating laboratory findings to human treatment requires careful clinical trials, safety evaluations, and long-term studies. Yet the momentum is clear. The door is now open to a future in which the brain’s own immune cells are not the enemies of recovery, but its architects.

“This is about more than just treating stroke,” said Prof Dheen. “It’s about changing how we harness the power of the brain’s own biology to heal itself.”

A Future Worth Fighting For

As scientists push forward, the promise of HDACi therapy reminds us that medical revolutions often come not from new inventions, but from seeing old tools in new ways. In the quiet, microscopic dance of genes and immune cells, hope is being rewritten—one brain at a time.

Stroke may strike swiftly and cruelly, but science is catching up. And thanks to the brilliant minds at NUS Medicine and their partners, a new story is being written—one where healing begins not with the clock, but with the cells that call the brain home.

Reference: Kevin Jayaraj et al, Spatial Transcriptomic Analysis Reveals HDAC Inhibition Modulates Microglial Dynamics to Protect Against Ischemic Stroke in Mice, Glia (2025). DOI: 10.1002/glia.70035

TweetShareSharePinShare

Recommended For You

Health and Medicine

America’s Babies Are Missing Gut Guardians That Protect Them for Life

July 8, 2025
Health and Medicine

The Hidden Heart Risks of Sleeping in Brightness

July 8, 2025
Graphical abstract. Credit: Current Biology (2025). DOI: 10.1016/j.cub.2025.05.057
Health and Medicine

When Vision Fades, the Eye Fights Back with Hidden Networks

July 8, 2025
Health and Medicine

Your Brain Keeps Growing New Neurons Even in Old Age

July 5, 2025
Health and Medicine

This Pig Kidney Survived in a Human Body for 61 Days and Changed Everything

July 4, 2025
Woman hand checking lumps on her breast for signs of breast cancer on white background. Healthcare concept. Cancer self check; healthy girl.
Health and Medicine

One Hormone Combo Raises Cancer Risk While Another May Lower It

July 4, 2025
Two-photon microscopy captures axonal segments in a living brain, enabling researchers to quantify structural changes in specialized areas under noninvasive low-intensity repetitive transcranial magnetic stimulation (rTMS). A zoomed-out survey of the brain area (A) shows complex networks of neurons, visible via fluorescent marker. Insets (B and C) show specialized axonal endings (termed "boutons") where synapses form. TB axon: "terminaux boutons" are short protrusions from the axon shaft typically connecting neurons in a local area. EPB axon: "en passant boutons" are small bead-like structures along axons typically connecting distal regions. Credit: B. Fulopova (Queen's University).
Health and Medicine

Magnetic Brain Pulses Awaken Lost Connections in Alzheimer’s

July 4, 2025
Health and Medicine

The Brain’s Sugar Secret Could Be the Key to Beating Alzheimer’s

July 4, 2025
Cytomegalovirus. Credit: CDC/Dr. Edwin P. Ewing, Jr. (PHIL #958), 1982.
Health and Medicine

The Secret Door That Lets a Silent Virus Harm Newborns

July 4, 2025
Next Post
Skeletal representation (%MAU) of thrush remains from Pollentia. The color gradient indicates the relative abundance of skeletal elements, with darker shades representing higher %MAU values. Credit: International Journal of Osteoarchaeology (2025). DOI: 10.1002/oa.3416

Ancient Roman Fast Food Found in a Cesspit in Spain

An idealized illustration of the Xiaohe burials with two types of posts. Left) Oval shaped end with extrusions. Right) Rounded end without extrusions. Credit: Asian Archaeology (2025). DOI: 10.1007/s41826-025-00105-2

Ancient Boat Coffins Unearthed in the Desert Reveal Secrets of a Forgotten Civilization

The extinct proboscidean species Notiomastodon platensis is observed feeding on Chilean palm fruit in La Campana National Park. Credit: Mauricio Álvarez

Lost Giants of South America Were Once Gardeners of the Ancient World

Legal

  • About Us
  • Contact Us
  • Disclaimer
  • Editorial Guidelines
  • Privacy Policy
  • Terms and Conditions

© 2025 Science News Today. All rights reserved.

No Result
View All Result
  • Biology
  • Physics
  • Chemistry
  • Astronomy
  • Health and Medicine
  • Psychology
  • Earth Sciences
  • Archaeology
  • Technology

© 2025 Science News Today. All rights reserved.

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.